Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2022

29.11.2021 | Review Article

Cellular components of the idiopathic epiretinal membrane

verfasst von: Rafael André da Silva, Vinicius Moraes de Paiva Roda, Monique Matsuda, Paula Veloso Siqueira, Gabriela Jesus Lustoza-Costa, Davi Chen Wu, Dânia Emi Hamassaki

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic epiretinal membrane (iERM) is a fibrocellular proliferation on the inner surface of the retina, which leads to decreased visual acuity and even central visual loss. As iERM is associated to advanced age and posterior vitreous detachment, a higher prevalence is expected with increasing life expectancy and aging of the global population. Although various cell types of retinal and extra-retinal origin have been described in iERMs (Müller glial cells, astrocytes, hyalocytes, retinal pigment epithelium cells, myofibroblasts, and fibroblasts), myofibroblasts have a central role in collagen production and contractile activity. Thus, myofibroblast differentiation is considered a key event for the iERM formation and progression, and fibroblasts, Müller glial cells, hyalocytes, and retinal pigment epithelium have been identified as myofibroblast precursors. On the other side, the different cell types synthesize growth factors, cytokines, and extracellular matrix, which have a crucial role in ERM pathogenesis. In the present review, the major cellular components and their functions are summarized, and their possible roles in the iERM formation are discussed. By exploring in detail the cellular and molecular aspects of iERM, we seek to contribute for better understanding of this fibrotic disease and the origin of myofibroblasts, which may eventually drive to more targeted therapeutic approaches.
Literatur
1.
Zurück zum Zitat Gass JDM (1997) Macular dysfunction caused by vitreous and vitreomacular interface abnormalities. In: Gass JDM (ed) Stereoscopic atlas of macular diseases: diagnosis and treatment. Mosby, St Louis, pp 938–950 Gass JDM (1997) Macular dysfunction caused by vitreous and vitreomacular interface abnormalities. In: Gass JDM (ed) Stereoscopic atlas of macular diseases: diagnosis and treatment. Mosby, St Louis, pp 938–950
12.
Zurück zum Zitat Foos RY (1977) Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 16:416–422PubMed Foos RY (1977) Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 16:416–422PubMed
23.
Zurück zum Zitat Oberstein SYL, Byun J, Herrera D, Chapin EA, Fisher SK, Lewis GP (2011) Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis 17:1794–1805PubMedPubMedCentral Oberstein SYL, Byun J, Herrera D, Chapin EA, Fisher SK, Lewis GP (2011) Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis 17:1794–1805PubMedPubMedCentral
33.
Zurück zum Zitat Vinores SA, Campochiaro PA, Conway BP (1990) Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 31:14–28PubMed Vinores SA, Campochiaro PA, Conway BP (1990) Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 31:14–28PubMed
43.
Zurück zum Zitat Ponsioen TL, van Luyn MJA, van der Worp RJ, Pas HH, Hooymans JMM, Los LI (2008) Human retinal Müller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol Vis 14:652–660PubMedPubMedCentral Ponsioen TL, van Luyn MJA, van der Worp RJ, Pas HH, Hooymans JMM, Los LI (2008) Human retinal Müller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol Vis 14:652–660PubMedPubMedCentral
48.
71.
Zurück zum Zitat Nuzzi R, Bergandi L, Zabetta LC, D’Errico L, Riscaldino F, Menegon S, Silvagno F (2020) In vitro generation of primary cultures of human hyalocytes. Mol Vis 26:818–829PubMedPubMedCentral Nuzzi R, Bergandi L, Zabetta LC, D’Errico L, Riscaldino F, Menegon S, Silvagno F (2020) In vitro generation of primary cultures of human hyalocytes. Mol Vis 26:818–829PubMedPubMedCentral
74.
Zurück zum Zitat Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T (2007) Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes. https://doi.org/10.2337/db06-0581CrossRefPubMed Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T (2007) Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes. https://​doi.​org/​10.​2337/​db06-0581CrossRefPubMed
79.
Zurück zum Zitat Chen Z, Shao Y, Li X (2015) The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR. Mol Vis 21:706–710PubMedPubMedCentral Chen Z, Shao Y, Li X (2015) The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR. Mol Vis 21:706–710PubMedPubMedCentral
81.
Zurück zum Zitat Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C (2012) Pirfenidone inhibits transforming growth factor- β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Mol Vis 18:1010–1020PubMedPubMedCentral Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C (2012) Pirfenidone inhibits transforming growth factor- β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Mol Vis 18:1010–1020PubMedPubMedCentral
83.
Zurück zum Zitat Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC, Roberts AB (2004) Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 84:1245–1258CrossRefPubMed Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC, Roberts AB (2004) Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 84:1245–1258CrossRefPubMed
Metadaten
Titel
Cellular components of the idiopathic epiretinal membrane
verfasst von
Rafael André da Silva
Vinicius Moraes de Paiva Roda
Monique Matsuda
Paula Veloso Siqueira
Gabriela Jesus Lustoza-Costa
Davi Chen Wu
Dânia Emi Hamassaki
Publikationsdatum
29.11.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2022
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-021-05492-7

Weitere Artikel der Ausgabe 5/2022

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2022 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.